Clinical Trial Update: Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Chronic Kidney Disease [Phase 1]

View source ↗

Summary

Phase 1 trial update of a bone marrow-derived mesenchymal stem cell therapy for chronic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Bone marrow-derived mesenchymal stem cell therapy (bone marrow-derived mesenchymal stem cells)

Snippet

Sponsor: LaTonya J. Hickson | Conditions: Chronic Kidney Diseases | Phase 1 | Status: COMPLETED